FDLI: Advertising & Promotion for Medical Products

ProPharma will be attending the FDLI Advertising & Promotion for Medical Products Conference 2026, taking place October 28–29, 2026, at the JW Marriott in Washington, D.C. The conference convenes leaders from across the life sciences industry to examine evolving FDA expectations, enforcement trends, and the future of medical product advertising and promotion.

Today's promotional environment requires organizations to make informed, risk-based decisions while keeping pace with changing regulations and an increasingly digital marketplace. ProPharma helps companies confidently navigate these complexities by providing strategic guidance that supports compliant communications and effective commercialization.

Our team will be onsite to connect with industry peers, discuss emerging challenges, and share perspectives on promotional compliance, regulatory strategy, and cross-functional collaboration that drive successful product communications.